Concepedia

Publication | Closed Access

Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty

DOI

49

Citations

17

References

1997

Year

Jean‐Marc Lablanche, Eugène McFadden, Jean René Lusson, Bernard Bertrand, Jean‐Philippe Metzger, Victor Legrand, Gilles Grollier, Carlos Macaya, Bernard De Bruyne, Alec Vahanian,
Circulation

Abstract

Pretreatment with the low-molecular-weight heparin nadroparin continued for 3 months after balloon angioplasty had no beneficial effect on angiographic restenosis or on adverse clinical outcomes.

References

YearCitations

Page 1